Please login to the form below

Not currently logged in
Email:
Password:

Digital intelligence blog

Pharma insight on digital marketing, social media, mobile apps, online video, websites and interactive healthcare tools

Sanofi Genzyme brings The World Vs MS to Denmark

Firm's Communiqué Award winning campaign launches in another local market

Sanofi Genzyme The World Vs MS campaign

Sanofi’s Genzyme unit has brought the global The World Vs MS campaign to its latest local market, launching it in Denmark.

The ‘movement’ aims to solve the everyday challenges faced by those with multiple sclerosis, and encourages social media participants to post about it using the hashtag #twvsms.

The new Danish arm of the campaign also has its own Facebook page, which adds to existing global campaign accounts on Twitter, Facebook, Instagram and YouTube .

This year the global campaign, on which H4B supported Sanofi Genzyme, won the social media strategy award at the 2017 Communiqué Awards, where it was also a finalist in both the content management/curation and corporate social responsibility categories.

Commenting on Sanofi Genzyme and H4B’s social media win, the Communiqué judges said: “This was a really clever programme that created partnerships, both in and outside of MS, and delivered tangible outputs. It worked well from a social media and content perspective and was by far the best of the work we saw.

“There was a lot of polish and a lot of passion put into it and we look forward to seeing what they do in the future with it. The World vs. MS was a mature piece of work and one of the best campaigns we’ve seen – we need more work like this to raise everyone else’s standards.”

23rd August 2017

From: Marketing

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
KVA Digital

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

digital launch
How can virtual pharma companies de-risk new product launches?
The risks and challenges involved in taking specialty drugs, biopharmaceuticals and drug/device combinations to market...
Not waving but drowning. Reflections on data curation in the age of information overload
...
digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...

Infographics